CompletedPhase 2

The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery

Egypt92 participantsStarted 2023-10-30

Plain-language summary

The goal of this clinical trial is to assess the efficacy of pentoxifylline in reducing postsurgical complications for breast cancer patients undergoing breast cancer surgery. It aims to evaluate the efficacy of pentoxifylline on postoperative pain and wound healing.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult female patients aged 18 to 65 years
✓. Patients completed neoadjuvant chemotherapy cycles and scheduled for breast cancer surgery.

Exclusion criteria

✕. Patients on treatment regimen of phosphodiesterase inhibitors
✕. Patients who are taking antiplatelet or anticoagulant treatment
✕. Patients who are allergic to phosphodiesterase inhibitors
✕. History of recent hemorrhagic events
✕. Active peptic ulcer
✕. History of psychological problems
✕. History of chronic pain management
✕. Pregnancy or breastfeeding

What they're measuring

Postoperative level of pain

Timeframe: 24 hours after surgery

Trial details

NCT IDNCT06087237

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Post-Surgical Complication trials